Commentary: Evaluating potential glioma serum biomarkers, with future applications.
Interleukin-6
Malignant glioma
Neutrophil-lymphocyte ratio
Systemic inflammation
Journal
World journal of clinical oncology
ISSN: 2218-4333
Titre abrégé: World J Clin Oncol
Pays: United States
ID NLM: 101549149
Informations de publication
Date de publication:
24 May 2022
24 May 2022
Historique:
received:
28
11
2021
revised:
15
03
2022
accepted:
14
05
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
7
6
2022
Statut:
ppublish
Résumé
Systemic inflammation within malignant glioma is a topic of ongoing significance. In this commentary, we highlight recent findings from Gandhi
Identifiants
pubmed: 35662986
doi: 10.5306/wjco.v13.i5.412
pmc: PMC9153077
doi:
Types de publication
Journal Article
Langues
eng
Pagination
412-416Informations de copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: The authors deny any conflicts of interest.
Références
Int J Clin Exp Med. 2015 Jun 15;8(6):9114-20
pubmed: 26309566
Cancer Res. 2016 Nov 15;76(22):6680-6689
pubmed: 27758882
Int J Neurosci. 2017 Mar;127(3):210-217
pubmed: 27050560
Br J Cancer. 2020 Feb;122(3):295-305
pubmed: 31666668
World Neurosurg. 2019 Jul;127:e261-e267
pubmed: 30898756
Lancet Oncol. 2013 May;14(6):e218-28
pubmed: 23639322
Front Pharmacol. 2018 Aug 14;9:886
pubmed: 30154718
Front Oncol. 2020 Apr 17;10:478
pubmed: 32363159
Nat Rev Neurol. 2015 Oct;11(10):556-66
pubmed: 26369507
Dose Response. 2020 Jul 9;18(3):1559325820938279
pubmed: 32694960
World J Surg Oncol. 2019 Aug 31;17(1):152
pubmed: 31472673
Acta Neuropathol. 1990;80(3):287-94
pubmed: 2399810
Asian Pac J Cancer Prev. 2013;14(9):5225-30
pubmed: 24175805
J Neurooncol. 2011 Mar;102(1):35-41
pubmed: 20607353
Neurosurgery. 2013 Jun;72(6):1031-8; discussion 1038-9
pubmed: 23426156
Glia. 2011 Aug;59(8):1169-80
pubmed: 21446047
Cancer Manag Res. 2019 Apr 15;11:3227-3236
pubmed: 31114362
J Neurosurg. 2009 Mar;110(3):572-82
pubmed: 19199469
Neuro Oncol. 2006 Jul;8(3):261-79
pubmed: 16775224
Oncologist. 2016 Feb;21(2):214-9
pubmed: 26834160
World Neurosurg. 2019 Dec;132:e585-e590
pubmed: 31442642
Oncologist. 2015 May;20(5):562-7
pubmed: 25862748
PLoS One. 2014 Nov 21;9(11):e112945
pubmed: 25415278
J Neurosurg. 2001 Jan;94(1):97-101
pubmed: 11147905
World J Clin Oncol. 2021 Oct 24;12(10):947-959
pubmed: 34733616
Nat Commun. 2020 Oct 5;11(1):4997
pubmed: 33020472
Cancer Biomark. 2014;14(2-3):185-94
pubmed: 24878820
J Neurosurg. 2018 Sep;129(3):583-592
pubmed: 29099300
J Neurooncol. 2014 Mar;117(1):67-76
pubmed: 24477622
Cell Commun Signal. 2017 Dec 19;15(1):54
pubmed: 29258522
Neurol Res. 2018 Nov;40(11):917-922
pubmed: 30074469
Signal Transduct Target Ther. 2020 Feb 21;5(1):10
pubmed: 32296044
Cancers (Basel). 2021 Nov 18;13(22):
pubmed: 34830935
Clin Nucl Med. 2012 Sep;37(9):838-42
pubmed: 22889771
Nat Med. 2012 Jan 26;18(4):624-9
pubmed: 22281806
J Neurooncol. 1999 Jun;43(2):137-42
pubmed: 10533725
J Neurooncol. 2013 Jul;113(3):345-352
pubmed: 23670054
Front Neurol. 2021 Feb 01;11:610163
pubmed: 33597912
J Radiat Res. 2014 Jul;55(4):803-11
pubmed: 24676944
J Neurooncol. 2017 Nov;135(2):255-261
pubmed: 28756592
Neuro Oncol. 2018 Aug 2;20(9):1155-1161
pubmed: 29746665
PLoS One. 2016 Dec 8;11(12):e0167854
pubmed: 27930715
Crit Rev Oncol Hematol. 2021 Jul;163:103372
pubmed: 34062242
Oncol Lett. 2016 Jul;12(1):445-452
pubmed: 27347163
J Clin Neurosci. 2015 Dec;22(12):1964-8
pubmed: 26279502
Mol Cell Biochem. 2007 Oct;304(1-2):343-51
pubmed: 17551671